No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
www.cyfusebio.comNo one on the platform currently holds 4892.T.
No tracked institution reports a position in 4892.T as of their last filing.
No one on the platform has traded 4892.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4892.TCyfuse Biomedical K.K. | $670.00 | +0.45% | $6.8B | — |
| 206A.TPRISM BioLab Co.,LTD | $161.00 | -3.01% | $6.0B | — |
| 4539.TNippon Chemiphar Co., Ltd. | $1550.00 | +0.00% | $5.6B | — |
| 4556.TKAINOS Laboratories, Inc. | $2268.00 | +0.00% | $10.1B | — |
| 4576.TD. Western Therapeutics Institute, Inc. | $69.00 | -20.69% | $4.0B | — |
| 4582.TSymBio Pharmaceuticals Limited | $56.00 | +0.00% | $3.1B | — |
| 4598.TDelta-Fly Pharma, Inc. | $111.00 | -3.48% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry